G2098 (HCPCS) Reimbursement & Policy | OpenPayer

Summary & Overview

HCPCS G2098: Frailty with Dementia Medication in Patients 66+

HCPCS Level II code G2098 designates a patient group aged 66 and older with at least one documented encounter for frailty during the measurement period and a dispensed dementia medication during the measurement period or the prior year. As a claims-derived measure, it is used to identify older adults with concurrent frailty and pharmacologically treated dementia, which has implications for care coordination, medication management, and quality reporting across payer programs. Key national payers relevant to this code include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare.

Readers will find an overview of the clinical and administrative context for G2098, including its role in stratifying high-risk older adults, typical sites of documentation and dispensing, and how payers incorporate such measures into quality frameworks. The publication summarizes benchmarks and reporting considerations where available, notes policy and coding updates affecting measure implementation, and provides clinical context on why identifying frailty alongside dementia medication use matters for population health management. Data not available in the input is clearly indicated where applicable.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG2098HCPCS Level IIfrailtydementia medicationquality measuregeriatricsclaims-based measurepharmacy dispensingambulatory care

Billing Code Overview

HCPCS Level II code G2098 identifies patients aged 66 years and older who have at least one claim or encounter documenting frailty during the measurement period and who received a dispensed medication for dementia either during the measurement period or in the year prior. This code represents a measure-derived classification used to capture a specific patient subgroup defined by age, frailty documentation, and dementia pharmacotherapy.

Service type: Quality measure / patient stratification derived from claims and pharmacy dispensing data
Typical site of service: Ambulatory care and pharmacy settings where encounters, claims, and medication dispensing are recorded

Clinical & Coding Specifications

Clinical Context

A typical patient is a 78-year-old community-dwelling adult with progressive cognitive decline and documented frailty who presents for routine follow-up to a primary care clinician or geriatrician. The patient has prior encounters identifying frailty phenotypes (weight loss, slow gait, exhaustion) during the measurement period and currently has a prescription dispensed for a dementia medication such as donepezil, memantine, rivastigmine, or galantamine either during the measurement period or in the 12 months before. Clinical workflow includes a review of problem list and medication fills, verification of dementia diagnosis and frailty documentation in the chart, reconciliation of outpatient pharmacy claims, and coding for performance or quality measurement. Typical encounter locations include outpatient primary care clinics, geriatric clinics, memory disorder centers, and long-term care or assisted living facility visits where medication administration and frailty assessments are documented. Documentation elements collected in the visit note include age (>=66 years), evidence of frailty (clinical assessment or ICD-10 code), medication name and dispense date, and dates of relevant encounters to support the performance measure.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	Use when additional work or complexity is documented beyond typical visit requirements (rare for cognitive med follow-up but may apply when extended evaluation is performed).

HCPCS G8873: Needle Localization Specimen Verification

HCPCS-G9210-HEPATITIS-C-QUANTITATIVE-RNA-TESTING-NOT-PERFORMED-4-12-WEEKS

HCPCS G9210: Hepatitis C Quantitative RNA Test Not Performed (4-12 Weeks)

HCPCS-G9518-ACTIVE-INJECTION-DRUG-USE-DOCUMENTATION

HCPCS G9518: Documentation of Active Injection Drug Use

HCPCS-G9760-HOSPICE-SERVICES-USED-DURING-MEASUREMENT-PERIOD

HCPCS G9760: Patients Using Hospice Services During Measurement Period

HCPCS-G0151-HOME-PHYSICAL-THERAPY-15-MINUTE

HCPCS G0151: Physical Therapy in Home Health Setting

HCPCS-G8495-CKD-MEASURES-COMPLETE

HCPCS G8495: Completion of CKD Quality Measures Bundle

HCPCS-G9674-CLINICAL-ASCVD-PATIENTS

HCPCS G9674: Patients with Clinical ASCVD Diagnosis

HCPCS-G8485-DIABETES-MEASURES-REPORTING-INTENT

HCPCS G8485: Diabetes Mellitus Measures Group

HCPCS-G0559-POST-OPERATIVE-FOLLOW-UP-COMPLEXITY

HCPCS G0559: Post-Operative Follow-Up Visit Complexity

HCPCS-G8580-ANTIPLATELET-MEDICATION-CONTRAINDICATED

HCPCS G8580: Antiplatelet Medication Contraindicated

Showing 1–10 of 1996

Taxonomy Code	Specialty	Notes
`207Q00000X`	Geriatric Medicine	Specialists who commonly manage frailty and dementia medication regimens.
`207L00000X`	Internal Medicine	Primary care internists who follow older adults and prescribe dementia medications.
`207R00000X`	Family Medicine	Family physicians providing longitudinal care and medication management for older adults.
`2084P0800X`	Neurology	Neurologists involved in dementia diagnosis and medication management.
`367A00000X`	Nurse Practitioner	Advanced practice providers who frequently manage chronic care, frailty screening, and prescriptions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`M62.84`	Frailty (musculoskeletal)	Directly documents frailty status used in the measure denominator and clinical assessment.
`F03.90`	Unspecified dementia, unspecified without behavioral disturbance	Common dementia diagnosis associated with prescriptions for dementia medications.
`G30.9`	Alzheimer's disease, unspecified	Primary neurodegenerative diagnosis prompting dementia medication therapy.
`F02.80`	Dementia in other diseases classified elsewhere without behavioral disturbance	Used when dementia is secondary to other neurologic conditions and dementia medications are prescribed.
`R54`	Age-related physical debility	Used to document functional decline and frailty-related conditions in older adults.
`R53.1`	Weakness	Common clinical feature contributing to frailty assessments.
`R26.2`	Difficulty in walking, not elsewhere classified	Gait disturbance often assessed as part of frailty evaluation.
`R63.4`	Abnormal weight loss	Weight loss is a core component of frailty screening and documentation.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly used for follow-up visits where frailty is documented and dementia medication reconciliation is performed.
`99214`	Office or other outpatient visit for the evaluation and management of an established patient, typically 25 minutes	Used when visits require moderate complexity evaluation, medication review, and frailty assessment.
`99304`	Initial nursing facility care, per day, for the evaluation and management of a patient, typically 20 minutes	Applicable for patients in long-term care or skilled nursing where frailty and dementia medication dispensing are assessed.
`99307`	Subsequent nursing facility care, per day, for the evaluation and management of a patient, typically 10 minutes	Applied for ongoing monitoring of frail nursing facility residents on dementia medications.
`99483`	Assessment of and care planning for a patient with cognitive impairment including caregiver needs; typically used for comprehensive dementia care management	Often performed alongside documentation of frailty and medication management as part of comprehensive cognitive care planning.

OpenPayer